アジア太平洋地域における細胞・遺伝子治療エコシステムの推進

Webinar Overview 

複数分野にまたがる最前線の科学領域として、細胞・遺伝子治療は難病治療における可能性を解き放ち、患者様の暮らしに変化をもたらします。投資機会の勢いに後押しされる一方で、アジア太平洋地域に拠点を置くバイオテクノロジー企業の前には、臨床業務やマーケットアクセスにおける課題が立ちはだかっています。

Join our online webinar and gain an in-depth understanding of the opportunities of cell and gene therapeutic product development and market entry strategies in this fast-evolving industry. Investigate the prospectus of operational excellence, investigator engagement, as well as patient recruitment to accelerate the journey. Additionally, explore Fortrea's solution for navigating the complexity of clinical studies in cell and gene therapy and understand the best practices in supporting the success of both emerging biotech and large pharmaceutical sponsors.

addition to the online presentations, feel free to book a seat at the actual site in Seoul, Korea, to join face-to-face discussions with Fortrea experts and key stakeholders covering the cell and gene therapy ecosystem. Share insights from various facets on advancing CGT clinical development in Asia Pacific.

Learnings

• In-depth insights towards the evolving regulatory framework for cell and gene therapy in the US as well as the major CGT market in APAC regions.
• Navigating the complexity in cell and gene therapy studies, leveraging resources on hospital infrastructure, clinicians, as well as chain logistics to ease the burden of investigators and sites.
• Exploring Fortrea’s dedicated infrastructure and expertise in the CGT arena.

内容

15:00-15:15 | Landscape & Regulatory

Global CGT landscape and navigating the Regulatory Landscape

15:15-15:30 | Insights from sites

Addressing the Complexities of Conducting CGT clinical trials

15:30-15:45 | Commercialization

Advancing cutting-edge therapies from bench-to-bedside

15:45-16:00 | Operation Excellence

From Benchtop to Patient -Manufacturing Considerations for Clinical Development of Advanced Therapeutics

16:00-16:30 | Panel Discussion

Advancing CGT trial ecosystem in APAC